Introduction
This study aimed to determine whether single nucleotide polymorphisms in the growth hormone receptor ( GHR ) and insulin-like growth factor 2 receptor ( IGF2R ) genes are associated with different craniofacial phenotypes.
Methods
A total of 596 orthodontic and 98 orthognathic patients from 4 cities in Brazil were included for analyses. Angular and linear cephalometric measurements were obtained, and phenotype characterizations were performed. Genomic DNA was collected from buccal cells and single nucleotide polymorphisms in GHR (rs2910875, rs2973015, rs1509460) and IGF2R (rs2277071, rs6909681, rs6920141) were genotyped by polymerase chain reactions using TaqMan assay. Genotype–phenotype associations were assessed in the total sample (statistical significance was set at P <8.333 × 10 −3 ) and by a meta-analytic approach implemented to calculate the single effect size measurement for the different cohorts.
Results
Rare homozygotes for the GHR rs2973015 showed increased measurements for the lower anterior facial height (ANS-Me) and mandibular sagittal lengths (Co-Gn and Go-Pg). In contrast, common homozygotes for the IGF2R rs6920141 presented reduced measurements for these dimensions (ANS-Me and Go-Pg). Furthermore, the less common homozygotes for IGF2R rs2277071 had reduced maxillary sagittal length (Ptm′-A′). The meta-analytical approach replicated the associations of rs2973015 with ANS-Me, rs2277071 with Ptm′-A′, and rs6920141 with Go-Pg.
Conclusions
Our results provide further evidence that GHR contributes to the determination of mandibular morphology. In addition, we report that IGF2R is a possible gene associated with variations in craniofacial dimensions. Applying meta-analytical approaches to genetic variation data originating from likely underpowered samples may provide additional insight regarding genotype and/or phenotype associations.
Highlights
- •
Growth hormone receptor ( GHR ) and insulin-like growth factor 2 receptor ( IGF2R ) participate in the physiology of skeletal growth and development.
- •
Rare homozygotes for GHR rs2973015 showed increased ANS-Me, Co-Gn, and Go-Pg measures.
- •
Common homozygotes for IGF2R rs6920141 presented reduced ANS-Me and Go-Pg measures.
- •
Less common homozygotes for IGF2R rs2277071 had reduced Ptm′-A′ measures.
- •
Some of the associations did not remain significant after meta-analysis.
Various proteins and their encoding genes have been implicated in fetal, neonatal, and postnatal development. Among them, the growth hormone (GH), insulin-like growth factors 1 and 2 (IGF1 and IGF2), and their associated receptors (GH receptor [GHR], insulin-like growth factors 1 receptor [IGF1R], and insulin-like growth factors 2 [IGF2R]) have been recognized for playing an important role in the physiology of skeletal growth and development. GH and insulin-like growth factors (IGFs) must bind to their receptors to perform their functions and trigger specific signaling pathways. Alterations in these receptors could cause phenotypic variations such as idiopathic short stature or underdevelopment of facial bones. The presence of GHR and IGF1R in the mandibular condyle , suggests they can affect mandibular morphology and thus craniofacial skeleton. Previous studies have reported associations between single nucleotide polymorphisms (SNPs) in or flanking GHR and different craniofacial phenotypes, suggesting that this gene might be involved in normal variations of craniofacial morphology.
IGF2R works differently, binding to IGF2 and, although with lower affinity, to insulin and IGF1. IGFs promote cartilage and bone development. When IGF2 binds to the IGF2R, instead of initiating a signaling response to perform its functions, IGF2R causes uptake of IGF2, transporting it to the lysosomes for further degradation. Thus, this receptor has been recognized as a controller of extracellular IGF levels and regulator of the growth-promoting function of these growth factors during development. , A previous study mapped susceptibility loci for mandibular prognathism to chromosomes 1p36, 6q25, and 1913.2, suggesting that these chromosomal loci are linked to this mandibular phenotype. Then, considering that IGF2R is located in the 6q25.3 region, we hypothesized that this gene is involved in determining the morphology of craniofacial structures.
Although some aspects of the craniofacial growth have been extensively studied, the molecular regulation of postnatal development is still largely elusive. Our study aimed to assess whether genetic variants in GHR and IGF2R are associated with specific craniofacial phenotypes. Therefore, we tested 3 SNPs in GHR (rs2910875, rs2973015, rs1509460) that were previously suggested of having a possible role in the etiology of the Class III phenotype. , In addition, we genotyped 3 SNPs (rs2277071, rs6909681, rs6920141) flanking D6S305, which is near to IGF2R , because this microsatellite marker was linked to mandibular prognathism.
Material and methods
This cross-sectional multicenter study was approved by the Research Ethics Committees of the University Hospital Antônio Pedro from the Fluminense Federal University (33791314.3.0000.5243), School of Dentistry of Ribeirão Preto from the University of São Paulo (50765715.3.0000.5419), Positivo University (80846317.8.0000.0093), and the University of Pittsburgh (no. 12080056). Written informed consent was obtained from all participants or their legal guardians.
Clinical and radiographic records from Brazilian subjects were assessed. Orthodontic patients from private practice and graduate orthodontic clinics in 3 cities (Rio de Janeiro [mean age, 24.7 ± 10.7 years; 124 male, 210 female], Manaus [mean age, 26.5 ± 11.0 years; 51 male, 79 female], and Ribeirão Preto [mean age, 14.9 ± 7.0 years; 65 male, 68 female]) located in different regions of Brazil were selected. In addition, a sample of patients presenting severe skeletal sagittal and/or vertical disharmonies, which required orthognathic surgery, were recruited from another center in the city of Curitiba [mean age, 29.3 ± 9.1 years; 33 male, 65 female] to test if the studied genetic variants are also involved in more severe phenotypes. Sample characteristics, location setting, and ethnic composition of each city were already described in a previous study. Patients who received previous orthodontic treatment, who had concomitant systemic medical conditions, craniofacial congenital or syndromic anomalies, a substantial number of teeth missing, or suffered facial trauma were excluded.
Digital cephalometric tracings of preorthodontic or preorthognathic lateral cephalograms, with the mandible in centric occlusion positioning, were performed by previously trained orthodontists using Dolphin 3D Imaging software (version 8.0; Dolphin Imaging and Management Solutions, Chatsworth, Calif). The Steiner’s ANB and Ricketts’ NBa-PtGn angles were measured to determine sagittal (skeletal malocclusion) and vertical (facial type) skeletal jaw relations. Subjects were classified as Class I (0°-4°), Class II (>4°), or Class III (<0°) and as mesofacial (87°-93°), dolichofacial (<87°), or brachyfacial (>93°) according to the ANB and NBa-PtGn angles, respectively. In addition, angular and linear measurements were obtained in both sagittal and vertical dimensions ( Fig 1 ; Table I ). Linear measurements were only assessed on radiographs with a ruler included in the image that enabled the corresponding size calibration in the Dolphin 3D Imaging software.
Variables | Rio de Janeiro | Manaus | Ribeirão Preto | Curitiba | Total |
---|---|---|---|---|---|
Skeletal malocclusion, n (%) | n = 334 | n = 130 | n = 132 | n = 98 | n = 596 |
Class I | 128 (38.3) | 68 (52.3) | 73 (55.3) | 21 (21.4) | 269 (45.1) |
Class II | 173 (51.8) | 50 (38.5) | 42 (31.8) | 19 (19.4) | 265 (44.5) |
Class III | 33 (9.9) | 12 (9.2) | 17 (12.9) | 58 (59.2) | 62 (10.4) |
Facial type, n (%) | n = 334 | n = 130 | n = 132 | n = 98 | n = 596 |
Mesofacial | 155 (46.4) | 68 (52.3) | 64 (48.5) | 24 (24.5) | 287 (48.2) |
Dolichofacial | 94 (28.1) | 33 (25.4) | 53 (40.2) | 15 (15.3) | 180 (30.2) |
Brachyfacial | 85 (25.4) | 29 (22.3) | 15 (11.4) | 59 (60.2) | 129 (21.6) |
Angular measurements (°), mean (SD) | n = 334 | n = 130 | n = 132 | n = 98 | n = 596 |
NBa-PtGn | 89.9 (5.5) | 89.8 (4.6) | 87.9 (4.6) | 94.2 (7.2) | 89.4 (5.1) |
SN-GoGn | 31.5 (7.0) | 30.5 (5.0) | 30.2 (6.4) | 30.6 (8.0) | 31.0 (6.5) |
y-axis | 60.3 (5.0) | 59.1 (3.8) | 59.7 (4.7) | 59.2 (6.1) | 59.9 (4.7) |
SNA | 84.7 (4.7) | 85.3 (4.0) | 83.1 (4.9) | 81.9 (4.7) | 84.5 (4.6) |
SNB | 80.5 (4.8) | 82.0 (4.2) | 80.3 (5.1) | 82.4 (6.4) | 80.7 (4.7) |
ANB | 4.3 (3.5) | 3.4 (2.5) | 2.9 (2.7) | −0.5 (5.4) | 3.8 (3.2) |
Linear measurements (mm), mean (SD) | n = 228 | n = 115 | n = 132 | – | n = 475 |
Co-Go | 54.3 (6.9) | 54.5 (5.4) | 57.1 (7.5) | – | 55.2 (6.9) |
S-Go | 74.9 (8.4) | 72.4 (6.4) | 73.5 (9.3) | – | 73.9 (8.3) |
ANS-Me | 63.3 (7.4) | 64.2 (5.9) | 60.0 (7.6) | – | 62.6 (7.3) |
N-Me | 113.1 (10.9) | 113.1 (7.7) | 109.6 (10.3) | – | 112.1 (10.1) |
S-N | 66.4 (6.1) | 66.3 (3.3) | 67.3 (5.8) | – | 66.6 (5.5) |
Co-Gn | 113.1 (11.0) | 116.8 (7.7) | 114.2 (11.2) | – | 114.3 (10.4) |
Go-Pg | 71.6 (7.6) | 75.7 (5.4) | 67.6 (7.7) | – | 71.5 (7.7) |
Ptm′-A′ | 50.6 (5.3) | 48.1 (3.1) | 49.8 (4.7) | – | 49.8 (4.7) |
The SNPs were chosen on the basis of their minor allele frequency >10%. Those selected in GHR (rs2910875, rs1509460, and rs2973015) are located in loci previously reported as candidate regions for mandible-related phenotypes. , , , , , SNPs in IGF2R (rs2277071, rs6909681, and rs6920141) were selected by their functional implications or location according to the SNP database ( www.ncbi.nlm.nih.gov/SNP ). The characteristics of the studied SNPs are shown in Table II .
Gene | Locus | Reference sequence | Type of alteration | Base change (context sequence) | Global MAF |
---|---|---|---|---|---|
GHR | 5p12 | rs2910875 | utr variant 3 prime | ATG[A ∗ /G]CTA | 0.4557/2282 |
GHR | 5p12 | rs2973015 | intron variant | TTT[A/G ∗ ]CTG | 0.4493/2250 |
GHR | 5p13.1 | rs1509460 | intron variant | CAG[G ∗ /T]ACT | 0.4407/2207 |
IGF2R | 6q25.3 | rs2277071 | intron variant | ATA[A ∗ /G]CAT | 0.2718/1361 |
IGF2R | 6q25.3 | rs6909681 | intron variant | AAC[A/T ∗ ]GTC | 0.4287/2147 |
IGF2R | 6q25.3 | rs6920141 | intron variant | TGT[C ∗ /T]GAT | 0.4629/2318 |
Genomic DNA was extracted and purified from buccal mucosa cells from saliva as previously reported. Genotyping was blindly performed by polymerase chain reactions (PCR) using end-point analysis and TaqMan assay on a real-time PCR system (Applied Biosystems Prism QuantStudio 6 Flex PCR System, Thermo Fisher Scientific, Foster City, Calif) according to an established protocol.
Statistical analysis
Statistical analyses were performed using 2-tailed tests (α = 0.05) on GraphPad Prism (GraphPad Software, San Diego, Calif) and Epi Info (Version 3.5.2.; Centers for Disease Control and Prevention, Atlanta, Ga). Chi-square (with Yate correction for continuity, when necessary) or Fisher exact tests were performed to evaluate the association between genotype and allele frequencies for each SNP and the skeletal malocclusion and facial type. Analysis of variance or Kruskal-Wallis tests were applied according to the data distribution (assessed by the Kolmogorov-Smirnov and Shapiro-Wilk tests) to compare the means or medians of cephalometric measurements according to genotypes, respectively. The threshold for statistical significance after Bonferroni correction for multiple testing was P <8.333 × 10 −3 (0.05/6.00 SNPs).
Chi-square tests were used to confirm the Hardy-Weinberg equilibrium for each SNP in each of the samples assessed, considering only the subjects with the phenotypes of reference (Class I malocclusion and mesofacial-type). Statistical power for the total sample was estimated using the Genetic Power Calculator tool assuming a marker allele frequency of 0.45, a prevalence of the phenotype of 0.1, the high-risk allele frequency of 0.3, D′ of 1.0, genotype relative risk for heterozygotes of 2.0, and genotype relative risk for homozygotes of 4.0. The power for the comparison of Class I vs Class III malocclusion (which had the smallest number of subjects) under an alpha of 0.05 was 80%. Changing the high-risk allele frequency for less than 0.3 or the effect sizes of heterozygotes and homozygotes for less than 2.0 or 4.0, respectively, will cause a substantial decline in the statistical power. All other comparisons such as Class I with Class II or mesofacial with dolichofacial and/or brachyfacial should have better power than the comparison of Class I with Class III.
Analyses were performed in the total sample, and with a concern that combining different geographic cohorts of Brazilians may be affected by population substructure, we tested a fixed-effects meta-analysis model to calculate the single effect size measurement for the different cohorts. This approach was performed only for the results that showed a significant association in the total sample using RevMan (version 5.1; Nordic Cochrane Centre, Copenhagen, Denmark). Heterogeneity was assessed by the I 2 Index. The genotypes were independently compared and also were pooled to perform analyses in dominant and recessive models. The analysis was done with and without the sample from Curitiba because this cohort included subjects with phenotypes of more severe craniofacial variations.
Results
The distribution of genotypes followed Hardy-Weinberg equilibrium (data not shown). There were no associations between the skeletal malocclusion or facial type and the genotype or allele frequencies for any SNP assessed in GHR and IGF2R in the total sample. Associations were detected when specific cephalometric measurements were assessed ( P <8.333 × 10 −3 ) ( Table III ). Rare homozygotes for the GHR rs2973015 marker showed increased measures for the lower anterior facial height (ANS-Me) and mandibular sagittal lengths (Co-Gn and Go-Pg). In contrast, common homozygotes for the IGF2R rs6920141 presented reduced measures for these dimensions (ANS-Me and Go-Pg). In addition, the less common homozygotes for the IGF2R rs2277071 had reduced maxillary length (Ptm′-A′).
SNPs | Genotypes | P value ∗ | ||
---|---|---|---|---|
GHR rs2973015 | AA | AG | GG | |
n | 72 | 145 | 119 | |
ANS-Me (mm), median (Q1-Q3) | 65.2 (60.8-70.1) | 63.3 (59.3-67.1) | 61.4 (58-65.6) | 0.006 |
Co-Gn (mm), median (Q1-Q3) | 116.5 (113.3-121.7) | 113.4 (108.3-119.5) | 113.6 (106.2-117.8) | 0.003 |
Go-Pg (mm), median (Q1-Q3) | 75.1 (71.3-78.7) | 72.7 (69.1-77.2) | 71.2 (66.8-75.2) | <0.001 |
IGF2R rs2277071 | AA | AG | GG | |
n | 45 | 161 | 258 | |
Ptm′-A′ (mm), median (Q1-Q3) | 47.4 (45.8-50.2) | 49.4 (47.1-52.5) | 49.4 (47.2-51.8) | 0.003 |
IGF2R rs6920141 | CC | CT | TT | |
n | 69 | 179 | 200 | |
ANS-Me (mm), median (Q1-Q3) | 62.1 (58.4-66.5) | 63.6 (58.6-67.4) | 61.1 (56.8-65.3) | 0.007 |
Go-Pg (mm), median (Q1-Q3) | 73.1 (69.3-78.3) | 72.4 (68.3-76.8) | 69.1 (64.8-74.5) | <0.001 |
∗ The threshold for statistical significance after Bonferroni correction was P <8.333 × 10 −3 .
The meta-analytical approach replicated the associations of rs2973015 with ANS-Me, rs2277071 with Ptm′-A′, and rs6920141 with Go-Pg. Subjects with the AA genotype for GHR rs2973015 showed higher ANS-Me measurements than subjects carrying the GG genotype ( P = 0.008, I 2 = 49%; Fig 2 ). In contrast, subjects with the AA genotype in IGF2R rs2277071 presented reduced measures for Ptm′-A′; this effect was stronger when both A alleles were present (recessive model for AA vs AG + GG ; P = 0.03, I 2 = 29%; Fig 3 ). Furthermore, subjects carrying at least 1 C allele for IGF2R rs6920141 had higher Go-Pg measurements (dominant model for CC + CT vs TT ; P = 0.02, I 2 = 48%; Fig 4 ). No other association remained significant when the single effect size measurement for the different cohorts was calculated in meta-analytic approaches ( Supplementary Figs 1-3 ).
The Curitiba sample showed significant differences in angular measurements of both jaws (SNA and SNB) for rs1509460 in GHR ( P <8.333 × 10 −3 ). Complete results are presented in the Supplementary Data ( Supplementary Tables I-V ).
Discussion
The roles of GH, IGFs, and their receptors have been well described and recognized for participating in the physiology of skeletal growth and development. The expression of some of them in the mandibular condyle, , , where cartilage-mediated growth occurs, suggests they can influence the mandibular morphology. Previous studies have suggested an association of missense mutations in GHR with the mandibular ramus height. , , , Our results showed that this gene could also affect the sagittal dimensions of the mandibular body.
Although P561T in exon 10 of GHR has already been associated with horizontal and longitudinal variations in the morphology of the mandible, , , this is the first study reporting association between rs2973015 and this dimension. Our findings indicated that this SNP could also affect lower anterior facial height. Interestingly, a previous study identified, by a principal component analysis, the involvement of this marker in the genetic background of horizontal and vertical maxillomandibular discrepancies in Brazilians. Because subjects carrying the AA genotype in the total sample presented significantly greater measures for Co-Gn and Go-Pg in the present study, we suggest that this SNP could be considered as a prognostic indicator of mandibular prognathism. It is important to mention that the genetic contribution of this SNP could vary on different populations; the present findings differ from other previously reported findings that found no association between this SNP and mandibular prognathism in a sample from the United States. In addition, the associations unveiled in the present study between this genetic variant and the measurements Co-Gn and Go-Pg were not replicated when the total sample was divided according to the region. These negative findings, however, are likely a direct result of a lack of statistical power because the cohorts contributing to these analyses had reduced sample sizes.
An interesting finding is that GHR could also be associated with the severity of skeletal variations. Subjects carrying the GG genotype for rs1509460 showed significantly higher angular measures for both jaws. This result from the cohort that had patients who underwent orthognathic surgery (therefore, from patients with more severe craniofacial deformities) could suggest a regulatory role of this genetic variant on the size and not as a contributor to a specific craniofacial characteristic.
Our results suggesting a role of IGF2R in variations of the craniofacial morphology may be explained by the regulatory function of the extracellular IGF levels of the receptor that this gene codes. IGF2R is a transmembrane receptor that transports IGF2 to lysosomes. IGF2R can remove IGF2 from circulation and extracellular medium and thus regulate the growth-promoting function of this growth factor. Increased systemic IGF2 levels could cause embryonic overgrowth and perinatal lethality ; in contrast, overexpression of IGF2R in a tissue-specific manner has been shown to cause a local reduction in organ size. It is important to mention that IGF2R not only binds to IGF2 but also to IGF1, although with less affinity. This means that alterations in IGF2R could also modify IGF1 levels and consequently their effect on target tissues. A previous study showed that Igf1 null mutant mice exhibited decreased craniofacial size and prominent changes in the facial and cranial areas. In humans, a previous case-control study of Chinese subjects found no association between IGF1 and mandibular prognathism. However, mandibular prognathism was defined on the basis of the facial features, presence of crossbite, and ANB angle (under −2.0°), and there could be a contribution of other structures besides the mandible for this phenotype.
Considering that IGFs are GH mediators and are believed to also stimulate growth independently by promoting cartilage and bone development, the association of rs6920141 with the Go-Pg measure may be due to the following: (1) SNPs in IGF2R that may alter the role of this receptor modifying the IGF levels exerting its function on the condyle and (2) the condylar growth that contributes to vertical height gains but also to the sagittal length of the mandible. In addition, a sagittal linear measurement for the maxilla (Ptm′-A′) showed a difference depending on the genotype for rs2277071. We believe that IGF has a role in the development of the maxilla because in the embryonic period, its presence in the maxillary prominences has been detected. Furthermore, although the maxilla has an intramembranous ossification, this bone is enlarged and displaced, to some extent, by the influence of the structures of the skull base that have endochondral ossification. Therefore, it appears that IGF2R may influence both the maxillary and mandibular morphology.
Some of the associations found in the combined sample did not remain significant when the single effect size measurement for the different cohorts was calculated in a meta-analysis. It has been reported that, as a whole, the ancestry contribution of Brazilians is 62% European, 21% African, and 17% Amerindian; however, the genetic admixture varies greatly depending on the region evaluated. For example, although the European contribution in the Southern region is higher with 77%, the Northern region has the largest contribution of Amerindian ancestry with 32%. The subjects included in our analyses belonged to cities located in different regions of the country; Rio de Janeiro and Ribeirão Preto are in the Southeast, Manaus in the North, and Curitiba in the Southern region of Brazil. Therefore, undetected population substructure is possible, and implementing approaches to minimize this effect is warranted.
Conclusions
In summary, our results provide additional evidence that GHR contributes to the determination of mandibular morphology. In addition, we report that IGF2R is a possible gene associated with variations in craniofacial dimensions.
Supplementary data
SNP | Class | Genotypes | Alleles | |||||
---|---|---|---|---|---|---|---|---|
GHR rs2910875 | AA | AG | GG | P value | A | G | P value | |
RJ | Class I | 25 (20.7) | 51 (42.1) | 45 (37.2) | Reference | 101 (41.7) | 141 (58.3) | Reference |
Class II | 25 (14.8) | 90 (53.3) | 54 (32) | 0.1526 | 140 (41.4) | 198 (58.6) | >0.9999 | |
Class III | 7 (25.9) | 11 (40.7) | 9 (33.3) | 0.8270 | 25 (46.3) | 29 (53.7) | 0.5466 | |
M | Class I | 18 (26.9) | 28 (41.8) | 21 (31.3) | Reference | 64 (47.8) | 70 (52.2) | Reference |
Class II | 11 (24.4) | 20 (44.4) | 14 (31.1) | 0.9465 | 42 (46.7) | 48 (53.3) | 0.8922 | |
Class III | 1 (9.1) | 7 (63.6) | 3 (27.3) | 0.3198 | 9 (40.9) | 13 (59.1) | 0.6473 | |
RP | Class I | 5 (7.9) | 36 (57.1) | 22 (34.9) | Reference | 46 (36.5) | 80 (63.5) | Reference |
Class II | 7 (18.9) | 19 (51.4) | 11 (29.7) | 0.2618 | 33 (44.6) | 41 (55.4) | 0.2953 | |
Class III | 4 (26.7) | 6 (40.0) | 5 (33.3) | 0.1136 | 14 (46.7) | 16 (53.3) | 0.3064 | |
RJ+M+RP | Class I | 48 (19.1) | 115 (45.8) | 88 (35.1) | Reference | 211 (42.0) | 291 (58.0) | Reference |
Class II | 43 (17.1) | 129 (51.4) | 79 (31.5) | 0.4584 | 215 (42.8) | 287 (57.2) | 0.8481 | |
Class III | 12 (22.6) | 24 (45.3) | 17 (32.1) | 0.8228 | 48 (45.3) | 58 (54.7) | 0.5892 | |
C | Class I | 3 (14.3) | 8 (38.1) | 10 (47.6) | Reference | 14 (33.3) | 28 (66.7) | Reference |
Class II | 7 (36.8) | 5 (26.3) | 7 (36.8) | 0.2554 | 19 (50.0) | 19 (50.0) | 0.1734 | |
Class III | 9 (15.8) | 23 (40.4) | 25 (43.9) | 0.956 | 41 (36.0) | 73 (64.0) | 0.8510 | |
RJ+M+RP+C | Class I | 51 (18.8) | 123 (45.2) | 98 (36.0) | Reference | 225 (41.4) | 319 (58.6) | Reference |
Class II | 50 (18.5) | 134 (49.6) | 86 (31.9) | 0.5337 | 234 (43.3) | 306 (56.7) | 0.5388 | |
Class III | 21 (19.1) | 47 (42.7) | 42 (38.2) | 0.8989 | 89 (40.5) | 131 (59.5) | 0.8710 |
GHR rs2973015 | AA | AG | GG | P value | A | G | P value | |
---|---|---|---|---|---|---|---|---|
RJ | Class I | 13 (10.2) | 56 (44.1) | 58 (45.7) | Reference | 82 (32.3) | 172 (67.7) | Reference |
Class II | 18 (10.5) | 80 (46.8) | 73 (42.7) | 0.8737 | 116 (33.9) | 226 (66.1) | 0.7252 | |
Class III | 1 (3.1) | 16 (50.0) | 15 (46.9) | 0.4339 † | 18 (28.1) | 46 (71.9) | 0.5510 | |
M | Class I | 30 (44.8) | 24 (35.8) | 13 (19.4) | Reference | 84 (62.7) | 50 (37.3) | Reference |
Class II | 22 (46.8) | 20 (42.6) | 5 (10.6) | 0.4296 | 64 (68.1) | 30 (31.9) | 0.4811 | |
Class III | 5 (41.7) | 7 (58.3) | 0 (0.0) | 0.1596 | 17 (70.8) | 7 (29.2) | 0.4973 | |
RJ+M | Class I | 43 (22.2) | 80 (41.2) | 71 (36.6) | Reference | 166 (42.8) | 222 (57.2) | Reference |
Class II | 40 (18.3) | 100 (45.9) | 78 (35.8) | 0.5299 | 180 (41.3) | 256 (58.7) | 0.6720 | |
Class III | 6 (13.6) | 23 (52.3) | 15 (34.1) | 0.3104 | 35 (39.8) | 53 (60.2) | 0.6342 | |
C | Class I | 8 (38.1) | 11 (52.4) | 2 (9.5) | Reference | 27 (64.3) | 15 (35.7) | Reference |
Class II | 6 (31.6) | 6 (31.6) | 7 (36.8) | 0.1081 | 18 (47.4) | 20 (52.6) | 0.1761 | |
Class III | 28 (48.3) | 19 (32.8) | 11 (19.0) | 0.2528 | 75 (64.7) | 41 (35.3) | >0.9999 | |
RJ+M+C | Class I | 51 (23.7) | 91 (42.3) | 73 (34.0) | Reference | 193 (44.9) | 237 (55.1) | Reference |
Class II | 46 (19.4) | 106 (44.7) | 85 (35.9) | 0.5370 | 198 (41.8) | 276 (58.2) | 0.3477 | |
Class III | 34 (33.3) | 42 (41.2) | 26 (25.5) | 0.1359 | 110 (53.9) | 94 (46.1) | 0.0339 ∗ |
GHR rs1509460 | GG | GT | TT | P value | G | T | P value | |
---|---|---|---|---|---|---|---|---|
RJ | Class I | 30 (26.8) | 58 (51.8) | 24 (21.4) | Reference | 118 (52.7) | 106 (47.3) | Reference |
Class II | 52 (32.1) | 73 (45.1) | 37 (22.8) | 0.5194 | 177 (54.6) | 147 (45.4) | 0.6639 | |
Class III | 5 (20.0) | 17 (68.0) | 3 (12.0) | 0.3214 | 27 (54.0) | 23 (46.0) | 0.8770 | |
M | Class I | 18 (27.3) | 37 (56.1) | 11 (16.7) | Reference | 73 (55.3) | 59 (44.7) | Reference |
Class II | 9 (19.6) | 29 (63.0) | 8 (17.4) | 0.6376 | 47 (51.1) | 45 (48.9) | 0.5867 | |
Class III | 3 (25.0) | 6 (50.0) | 3 (25.0) | 0.7866 | 12 (50.0) | 12 (50.0) | 0.6614 | |
RP | Class I | 15 (20.5) | 41 (56.2) | 17 (23.3) | Reference | 71 (48.6) | 75 (51.4) | Reference |
Class II | 11 (26.8) | 26 (63.4) | 4 (9.8) | 0.1920 | 48 (58.5) | 34 (41.5) | 0.1685 | |
Class III | 3 (17.6) | 5 (29.4) | 9 (52.9) | 0.0453 ∗ | 11 (32.4) | 23 (67.6) | 0.1253 | |
RJ+M+RP | Class I | 63 (25.1) | 136 (54.2) | 52 (20.7) | Reference | 262 (52.2) | 240 (47.8) | Reference |
Class II | 72 (28.9) | 128 (51.4) | 49 (19.7) | 0.6313 | 272 (54.6) | 226 (45.4) | 0.4475 | |
Class III | 11 (20.4) | 28 (51.9) | 15 (27.8) | 0.4819 | 50 (46.3) | 58 (53.7) | 0.2894 | |
C | Class I | 1 (4.8) | 14 (66.7) | 6 (28.6) | Reference | 16 (38.1) | 26 (61.9) | Reference |
Class II | 0 (0.0) | 17 (89.5) | 2 (10.5) | 0.2019 | 17 (44.7) | 21 (55.3) | 0.6506 | |
Class III | 5 (8.6) | 46 (79.3) | 7 (12.1) | 0.2039 | 56 (48.3) | 60 (51.7) | 0.2823 | |
RJ+M+RP+C | Class I | 64 (23.5) | 150 (55.1) | 58 (21.3) | Reference | 278 (51.1) | 266 (48.9) | Reference |
Class II | 72 (26.9) | 145 (54.1) | 51 (19.0) | 0.6141 | 289 (53.9) | 247 (46.1) | 0.3613 | |
Class III | 16 (14.3) | 74 (66.1) | 22 (19.6) | 0.0827 | 106 (47.3) | 118 (52.7) | 0.3825 |
∗ Statistically significant association (nominal level, P <0.05); † Chi-square test conditions were not met.
SNP | Facial type | Genotypes | Alleles | |||||
---|---|---|---|---|---|---|---|---|
GHR rs2910875 | AA | AG | GG | P value | A | G | P value | |
RJ | Mesofacial | 27 (18.4) | 72 (49) | 48 (32.7) | Reference | 126 (42.9) | 168 (57.1) | Reference |
Dolichofacial | 15 (16.7) | 45 (50) | 30 (33.3) | 0.9465 | 75 (41.7) | 105 (58.3) | 0.8483 | |
Brachyfacial | 15 (18.8) | 35 (43.8) | 30 (37.5) | 0.7189 | 65 (40.6) | 95 (59.4) | 0.6909 | |
M | Mesofacial | 15 (22.7) | 30 (45.5) | 21 (31.8) | Reference | 60 (45.5) | 72 (54.5) | Reference |
Dolichofacial | 5 (16.1) | 14 (45.2) | 12 (38.7) | 0.6907 | 24 (38.7) | 38 (61.3) | 0.4381 | |
Brachyfacial | 10 (38.5) | 11 (42.3) | 5 (19.2) | 0.2478 | 31 (59.6) | 21 (40.4) | 0.1019 | |
RP | Mesofacial | 10 (18.2) | 24 (43.6) | 21 (38.2) | Reference | 44 (40.0) | 66 (60.0) | Reference |
Dolichofacial | 5 (10.4) | 31 (64.6) | 12 (25.0) | 0.1023 | 41 (42.7) | 55 (57.3) | 0.7768 | |
Brachyfacial | 1 (8.3) | 6 (50.0) | 5 (41.7) | 0.7047 | 8 (33.3) | 16 (66.7) | 0.6467 | |
RJ+M+RP | Mesofacial | 52 (19.4) | 126 (47.0) | 90 (33.6) | Reference | 230 (42.9) | 306 (57.1) | Reference |
Dolichofacial | 25 (14.8) | 90 (53.3) | 54 (32) | 0.3413 | 140 (41.4) | 198 (58.6) | 0.6738 | |
Brachyfacial | 26 (22.0) | 52 (44.1) | 40 (33.9) | 0.8025 | 104 (44.1) | 132 (55.9) | 0.8131 | |
C | Mesofacial | 6 (25.0) | 9 (37.5) | 9 (37.5) | Reference | 21 (43.8) | 27 (56.3) | Reference |
Dolichofacial | 5 (33.3) | 3 (20.0) | 7 (46.7) | 0.5117 | 13 (43.3) | 17 (56.7) | >0.9999 | |
Brachyfacial | 8 (13.8) | 24 (41.4) | 26 (44.8) | 0.4653 | 40 (34.5) | 76 (65.5) | 0.2897 | |
RJ+M+RP+C | Mesofacial | 58 (19.9) | 135 (46.2) | 99 (33.9) | Reference | 251 (43.0) | 333 (57.0) | Reference |
Dolichofacial | 30 (16.3) | 93 (50.5) | 61 (33.2) | 0.5406 | 153 (41.6) | 215 (58.4) | 0.6866 | |
Brachyfacial | 34 (19.3) | 76 (43.2) | 66 (37.5) | 0.7240 | 144 (40.9) | 208 (59.1) | 0.5395 |
GHR rs2973015 | AA | AG | GG | P value | A | G | P value | |
---|---|---|---|---|---|---|---|---|
RJ | Mesofacial | 15 (9.8) | 71 (46.4) | 67 (43.8) | Reference | 101 (33.0) | 205 (67.0) | Reference |
Dolichofacial | 10 (10.8) | 45 (48.4) | 38 (40.9) | 0.8958 | 65 (34.9) | 121 (65.1) | 0.6944 | |
Brachyfacial | 7 (8.3) | 36 (42.9) | 41 (48.8) | 0.7483 | 50 (29.8) | 118 (70.2) | 0.5365 | |
M | Mesofacial | 27 (41.5) | 30 (46.2) | 8 (12.3) | Reference | 84 (64.6) | 46 (35.4) | Reference |
Dolichofacial | 21 (65.6) | 10 (31.3) | 1 (3.1) | 0.0602 | 52 (81.3) | 12 (18.8) | 0.0196 ∗ | |
Brachyfacial | 9 (31.0) | 11 (37.9) | 9 (31) | 0.0916 | 29 (50.0) | 29 (50.0) | 0.0759 | |
RJ+M | Mesofacial | 42 (19.3) | 101 (46.3) | 75 (34.4) | Reference | 185 (42.4) | 251 (57.6) | Reference |
Dolichofacial | 31 (24.8) | 55 (44.0) | 39 (31.2) | 0.4771 | 117 (46.8) | 133 (53.2) | 0.2989 | |
Brachyfacial | 16 (14.2) | 47 (41.6) | 50 (44.2) | 0.1836 | 79 (35.0) | 147 (65.0) | 0.0659 | |
C | Mesofacial | 7 (29.2) | 11 (45.8) | 6 (25.0) | Reference | 25 (52.1) | 23 (47.9) | Reference |
Dolichofacial | 7 (46.7) | 3 (20.0) | 5 (33.3) | 0.2554 | 17 (56.7) | 13 (43.3) | 0.8162 | |
Brachyfacial | 28 (47.5) | 22 (37.3) | 9 (15.3) | 0.2780 | 78 (66.1) | 40 (33.9) | 0.1127 | |
RJ+M+C | Mesofacial | 49 (20.2) | 112 (46.3) | 81 (33.5) | Reference | 210 (43.4) | 274 (56.6) | Reference |
Dolichofacial | 38 (27.1) | 58 (41.4) | 44 (31.4) | 0.2962 | 134 (47.9) | 146 (52.1) | 0.2577 | |
Brachyfacial | 44 (25.6) | 69 (40.1) | 59 (34.3) | 0.3383 | 157 (45.6) | 187 (54.4) | 0.5239 |
GHR rs1509460 | GG | GT | TT | P value | G | T | P value | |
---|---|---|---|---|---|---|---|---|
RJ | Mesofacial | 47 (33.8) | 67 (48.2) | 25 (18) | Reference | 161 (57.9) | 117 (42.1) | Reference |
Dolichofacial | 26 (29.9) | 39 (44.8) | 22 (25.3) | 0.4148 | 91 (52.3) | 83 (47.7) | 0.2450 | |
Brachyfacial | 14 (19.2) | 42 (57.5) | 17 (23.3) | 0.0801 | 70 (47.9) | 76 (52.1) | 0.0521 | |
M | Mesofacial | 19 (29.7) | 34 (53.1) | 11 (17.2) | Reference | 72 (56.3) | 56 (43.8) | Reference |
Dolichofacial | 6 (19.4) | 22 (71.0) | 3 (9.7) | 0.2503 | 34 (54.8) | 28 (45.2) | 0.8772 | |
Brachyfacial | 5 (17.2) | 16 (55.2) | 8 (27.6) | 0.3214 | 26 (44.8) | 32 (55.2) | 0.1573 | |
RP | Mesofacial | 13 (20.6) | 34 (54) | 16 (25.4) | Reference | 60 (47.6) | 66 (52.4) | Reference |
Dolichofacial | 13 (24.5) | 30 (56.6) | 10 (18.9) | 0.6771 | 56 (52.8) | 50 (47.2) | 0.5100 | |
Brachyfacial | 3 (20.0) | 8 (53.3) | 4 (26.7) | 0.9950 | 14 (46.7) | 16 (53.3) | >0.9999 | |
RP+M+RP | Mesofacial | 79 (29.7) | 135 (50.8) | 52 (19.5) | Reference | 293 (55.1) | 239 (44.9) | Reference |
Dolichofacial | 45 (26.3) | 91 (53.2) | 35 (20.5) | 0.7445 | 181 (52.9) | 161 (47.1) | 0.5779 | |
Brachyfacial | 22 (18.8) | 66 (56.4) | 29 (24.8) | 0.0739 | 110 (47.0) | 124 (53.0) | 0.0414 ∗ | |
C | Mesofacial | 0 (0.0) | 20 (83.3) | 4 (16.7) | Reference | 20 (41.7) | 28 (58.3) | Reference |
Dolichofacial | 0 (0.0) | 13 (86.7) | 2 (13.3) | 0.9608 | 13 (43.3) | 17 (56.7) | >0.9999 | |
Brachyfacial | 6 (10.2) | 44 (74.6) | 9 (15.3) | 0.2685 | 56 (47.5) | 62 (52.5) | 0.6066 | |
RJ+M+RP+C | Mesofacial | 79 (27.2) | 155 (53.4) | 56 (19.3) | Reference | 313 (54.0) | 267 (46.0) | Reference |
Dolichofacial | 45 (24.2) | 104 (55.9) | 37 (19.9) | 0.7594 | 194 (52.2) | 178 (47.8) | 0.5949 | |
Brachyfacial | 28 (15.9) | 110 (62.5) | 38 (21.6) | 0.0184 ∗ | 166 (47.2) | 186 (52.8) | 0.0499 ∗ |
∗ Statistically significant association (nominal level, P <0.05).
SNP | Class | Genotypes | Alleles | |||||
---|---|---|---|---|---|---|---|---|
IGF2R rs2277071 | AA | AG | GG | P value | A | G | P value | |
RJ | Class I | 6 (4.8) | 50 (40.0) | 69 (55.2) | Reference | 62 (24.8) | 188 (75.2) | Reference |
Class II | 6 (3.5) | 69 (40.6) | 95 (55.9) | 0.8607 | 81 (23.8) | 259 (76.2) | 0.8459 | |
Class III | 2 (6.5) | 8 (25.8) | 21 (67.7) | 0.3396 | 12 (19.4) | 50 (80.6) | 0.4086 | |
M | Class I | 13 (19.1) | 28 (41.2) | 27 (39.7) | Reference | 54 (39.7) | 82 (60.3) | Reference |
Class II | 12 (24.5) | 14 (28.6) | 23 (46.9) | 0.3697 | 38 (38.8) | 60 (61.2) | 0.8931 | |
Class III | 4 (33.3) | 5 (41.7) | 3 (25.0) | 0.4584 | 13 (54.2) | 11 (45.8) | 0.2615 | |
RP | Class I | 4 (5.7) | 19 (27.1) | 47 (67.1) | Reference | 27 (19.3) | 113 (80.7) | Reference |
Class II | 4 (9.8) | 17 (41.5) | 20 (48.8) | 0.1596 | 25 (30.5) | 57 (69.5) | 0.0709 | |
Class III | 0 (0.0) | 4 (25.0) | 12 (75.0) | 0.5916 | 4 (12.5) | 28 (87.5) | 0.4528 | |
RJ+M+RP | Class I | 23 (8.7) | 97 (36.9) | 143 (54.4) | Reference | 143 (27.2) | 383 (72.8) | Reference |
Class II | 22 (8.5) | 100 (38.5) | 138 (53.1) | 0.9324 | 144 (27.7) | 376 (72.3) | 0.8898 | |
Class III | 6 (10.2) | 17 (28.8) | 36 (61.0) | 0.5016 | 29 (24.6) | 89 (75.4) | 0.6454 | |
C | Class I | 2 (9.5) | 9 (42.9) | 10 (47.6) | Reference | 13 (31.0) | 29 (69.0) | Reference |
Class II | 1 (5.6) | 11 (61.1) | 6 (33.3) | 0.5194 | 13 (36.1) | 23 (63.9) | 0.6797 | |
Class III | 3 (5.6) | 20 (37.0) | 31 (57.4) | 0.6873 | 26 (24.1) | 82 (75.9) | 0.4115 | |
RJ+M+RP+C | Class I | 25 (8.8) | 106 (37.3) | 153 (53.9) | Reference | 156 (27.5) | 412 (72.5) | Reference |
Class II | 23 (8.3) | 111 (39.9) | 144 (51.8) | 0.8158 | 157 (28.2) | 399 (71.8) | 0.7903 | |
Class III | 9 (8.0) | 37 (32.7) | 67 (59.3) | 0.6171 | 55 (24.3) | 171 (75.7) | 0.4230 |
IGF2R rs6909681 | AA | AT | TT | P value | A | T | P value | |
---|---|---|---|---|---|---|---|---|
RJ | Class I | 27 (21.1) | 74 (57.8) | 27 (21.1) | Reference | 128 (50.0) | 128 (50.0) | Reference |
Class II | 51 (29.5) | 87 (50.3) | 35 (20.2) | 0.2466 | 189 (54.6) | 157 (45.4) | 0.2834 | |
Class III | 7 (21.2) | 21 (63.6) | 5 (15.2) | 0.7334 | 35 (53.0) | 31 (47.0) | 0.6809 | |
M | Class I | 17 (26.6) | 27 (42.2) | 20 (31.3) | Reference | 61 (47.7) | 67 (52.3) | Reference |
Class II | 13 (32.5) | 18 (45.0) | 9 (22.5) | 0.6005 | 44 (55.0) | 36 (45.0) | 0.3213 | |
Class III | 5 (41.7) | 5 (41.7) | 2 (16.7) | 0.4630 | 15 (62.5) | 9 (37.5) | 0.2659 | |
RP | Class I | 22 (32.8) | 32 (47.8) | 13 (19.4) | Reference | 76 (56.7) | 58 (43.3) | Reference |
Class II | 17 (41.5) | 15 (36.6) | 9 (22.0) | 0.5117 | 49 (59.8) | 33 (40.2) | 0.6731 | |
Class III | 5 (29.4) | 9 (52.9) | 3 (17.6) | 0.9277 | 19 (55.9) | 15 (44.1) | >0.9999 | |
RJ+M+RP | Class I | 66 (25.5) | 133 (51.4) | 60 (23.2) | Reference | 265 (51.2) | 253 (48.8) | Reference |
Class II | 81 (31.9) | 120 (47.2) | 53 (20.9) | 0.2753 | 282 (55.5) | 226 (44.5) | 0.1689 | |
Class III | 17 (27.4) | 35 (56.5) | 10 (16.1) | 0.4819 | 69 (55.6) | 55 (44.4) | 0.4235 | |
C | Class I | 4 (22.2) | 11 (61.1) | 3 (16.7) | Reference | 19 (52.8) | 17 (47.2) | Reference |
Class II | 4 (21.1) | 11 (57.9) | 4 (21.1) | 0.9418 | 19 (50.0) | 19 (50.0) | 0.8208 | |
Class III | 15 (27.8) | 25 (46.3) | 14 (25.9) | 0.5379 | 55 (50.9) | 53 (49.1) | >0.9999 | |
RJ+M+RP+C | Class I | 70 (25.3) | 144 (52.0) | 63 (22.7) | Reference | 284 (51.3) | 270 (48.7) | Reference |
Class II | 85 (31.1) | 131 (48.0) | 57 (20.9) | 0.3108 | 301 (55.1) | 245 (44.9) | 0.2049 | |
Class III | 32 (27.6) | 60 (51.7) | 24 (20.7) | 0.8497 | 124 (53.4) | 108 (46.6) | 0.5847 |